New research has identified the gene Egr-1 as a critical regulator of immune balance, offering hope for autoimmune disease therapies.

Fibrosis is associated with fibroblast activation mediated by transforming growth factor β (TGF-β); therefore, blocking TGF-β signaling pathways is a rational approach to antifibrotic therapy ...